Sumatriptan and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Ibrance (palbociclib). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Ibrance. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

51 people who take Sumatriptan and Ibrance together, and have interactions are studied.

Sumatriptan and Ibrance drug interactions.

What are the common drug interactions of Sumatriptan and Ibrance, by gender? *:

female:

Fatigue (feeling of tiredness)
White blood cell count decreased
Dry skin
Dyspnoea (difficult or laboured respiration)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Rash
Tumour marker increased
Breast cancer metastatic
Malignant neoplasm progression (cancer tumour came back)
Lacrimation increased

male:

n/a

What are the common drug interactions of Sumatriptan and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Disease progression

40-49:

Rash
Fatigue (feeling of tiredness)
Diarrhoea
White blood cell count decreased
Alopecia (absence of hair from areas of the body)
Eyelid ptosis (falling of the upper or lower eyelid)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Hypotension (abnormally low blood pressure)
Lacrimation increased
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

50-59:

Oxygen saturation decreased
Postmenopausal haemorrhage (post-menopausal bleeding)
Pyrexia (fever)
Rash
Tongue coated
Weight increased
Fatigue (feeling of tiredness)
White blood cell count decreased
Alopecia (absence of hair from areas of the body)
Back pain

60+:

Fatigue (feeling of tiredness)
Thrombocytopenia (decrease of platelets in blood)
Diarrhoea
Injection site discomfort
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Skin exfoliation (removal of the oldest dead skin cells)
Tumour marker increased
Vomiting
White blood cell count decreased

What are the existing conditions these people have? *

Breast Cancer Female: 16 people, 31.37%
Breast Cancer Metastatic: 11 people, 21.57%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 10 people, 19.61%
High Blood Pressure: 10 people, 19.61%
Breast Cancer: 7 people, 13.73%
Pain: 3 people, 5.88%
Metastases To Breast (cancer spreads to brain): 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously